Cardiology – Notable Articles of 2023 – Part 2

Rosuvastatin vs. Atorvastatin; Bempedoic Acid; Immediate versus staged PCI; Stroke Anticoagulation; Semaglutide in Obesity without Diabetes Resources: Rosuvastatin vs. Atorvastatin Treatment in Patients With Coronary Artery Disease – LODESTAR https://www.bmj.com/content/383/bmj-2023-075837 https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2023/08/23/19/37/lodestar Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients - CLEAR Outcomes trial https://www.nejm.org/doi/full/10.1056/NEJMoa2215024 https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2023/03/01/23/31/clear-outcomes Immediate versus staged complete revascularization in patients presenting with acute coronary syndrome and multivessel coronary disease: a prospective, open-label, non-inferiority, randomized trial - BIOVASC https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)00351-3/fulltext https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2023/03/01/23/40/biovasc Early versus Later Anticoagulation for Stroke with Atrial Fibrillation – ELAN trial https://www.nejm.org/doi/full/10.1056/NEJMoa2303048 https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2023/05/24/17/31/elan Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes – SELECT trial https://www.nejm.org/doi/full/10.1056/NEJMoa2307563 https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2023/11/09/15/04/select